Molecular mechanisms of maculopapular exanthema

Current Opinion in Infectious Diseases

Volumn 22, Issue 3, 2009, Pages 272-278

  Fernández, Tahia D ^a   Canto, Gabriela ^b   Blanca, Miguel ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b HOSPITAL UNIVERSITARIO INFANTA LEONOR   (Spain)

Author keywords

Chemokinescytokines; Oxidative stress; Skin, T lymphocytes

Indexed keywords

ALLOPURINOL; AMPICILLIN; ANTICONVULSIVE AGENT; CUTANEOUS T CELL ATTRACTING CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; SULFONAMIDE; CYTOKINE;

CD4+ T LYMPHOCYTE; CLINICAL FEATURE; DRESS SYNDROME; DRUG ERUPTION; DRUG INTERACTION; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; INFECTIOUS MONONUCLEOSIS; MACULOPAPULAR RASH; MOLECULAR MECHANICS; OXIDATIVE STRESS; PATHOLOGY; POLYMERASE CHAIN REACTION; REVIEW; SKIN TEST; TH0 CELL; TH1 CELL; VIRUS; DRUG HYPERSENSITIVITY; SKIN; VIRUS INFECTION;

CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; DRUG HYPERSENSITIVITY; HUMANS; OXIDATIVE STRESS; SKIN; VIRUS DISEASES;

EID: 65549089985     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e3283298e62     Document Type: Review

References (53)

1. Bigby M. Rates of cutaneous reactions to drugs. Arch Dermatol 2001; 137:765-770.
2. Fernández FJ, Puerta R, González L, et al. Fever and maculopapular exanthema as first manifestation of lymphoma. An Med Interna 2007; 24:204-205.
3. Matsushita T, Hasegawa M, Shirasaki F, et al. A case of acute cutaneous graftversus-host disease mimicking psoriasisvulgaris. Dermatology 2008; 216:64-67.
4. Hari Y, Urwyler A, Hurni M, et al. Distinct serum cytokine levels in drug and measles induced exanthema. Int Arch Allergy Immunol 1998; 120:225-229.
5. Klein J, Horejsi V. Defence against invaders. In: Klein J, Horejsi V, editors. Immunology, 2nd ed. Oxford: Blackwell Sci; 1997. pp. 532-595.
6. Dewdeney JM. Immunology of the antibiotics. In: Sela M, editor. The antigens, vol. 5. New York: Academic Press; 1997. pp. 73-245.
7. Wedderburn LR, Patel A, Varsani H, Woo P. The developing human immune system: T cell receptor repertoire of children and young adults shows a wide discrepancy in the frequency of persistent oligoclonal T cell expansions. Immunology 2001; 102:301-309.
8. Blanca M. Allergic reactions to penicillins. A changing world? Allergy 1995; 502:777-782.
9. Tsuge I, Okumura A, Kondo Y, et al. Allergen-specific T-cell response in patients with phenytoin hypersensitivity; simultaneous analysis of proliferation and cytokine production by carboxyfluorescein succinimidyl ester (CFSE) dilution assay. Allergol Int 2007; 56:149-155.
10. Torres MJ, Mayorga C, Fernández TD, et al. T cell assessment in allergic drug reactions during the acute phase according to the time of occurrence. Int J Immunopathol Pharmacol 2006; 19:119-130.
11. Torres MJ, Mayorga C, Cornejo-Garcia JA, et al. Monitoring nonimmediate allergic reactions to iodine contrast media. Clin Exp Immunol 2008; 152:233-238.
12. Park HJ, Kim HS, Kim HJ, et al. Immunohistochemical characterization of cutaneous drug eruptions by STI571. J Dermatol Sci 2005; 38:9-15.
13. Barbaud AM, Béné MC, Reichert-Penetrat S, et al. Immunocompetent cells and adhesion molecules in 14 cases of cutaneous drug reactions induced with the use of antibiotics. Arch Dermatol 1998; 134:1040-1041.
14. Yawalkar N, Shrikhande M, Hari Y, et al. Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug-induced cutaneous eruptions. J Allergy Clin Immunol 2000; 106:1171-1176.
15. Yawalkar N, Egli F, Hari Y, et al. Infiltration of cytotoxic T cells in drug-induced cutaneous eruptions. Clin Exp Allergy 2000; 30:847-855.
16. Hari Y, Urwyler A, Hurni M, et al. Distinct serum cytokine levels in drug-and measles-induced exanthema. Int Arch Allergy Immunol 1999; 120:225-229.
17. Dworzak MN, Fröschl G, Printz D, et al. Skin-associated lymphocytes in the peripheral blood of patients with atopic dermatitis: signs of subset expansion and stimulation. J Allergy Clin Immunol 1999; 103:901-906.
18. Antúnez C, Torres MJ, Mayorga C, et al. Different cytokine production and activation marker profiles in circulating cutaneous-lymphocyte- associated antigen T cells from patients with acute or chronic atopic dermatitis. Clin Exp Allergy 2004; 34:559-566.
19. Pichler WJ, Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy 2004; 59:809-820.
20. Rodriguez-Pena R, Lopez S, Mayorga C, et al. Potential involvement of dendritic cells in delayed-type hypersensitivity reactions to beta-lactams. J Allergy Clin Immunol 2006; 118:949-956.
21. Schmid DA, Depta JP, Pichler WJ. T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity. Clin Exp Allergy 2006; 36: 59-69.
22. Lopez S, Torres MJ, Rodríguez-Pena R, et al. Lymphocyte proliferation response in patients with delayed hypersensitivity reactions to heparins. Br J Dermatol 2008; 160:259-265. Heparins also induce exanthematic reactions with a predominance at the site of application of the drug. Dendritic cells of patients with delayed-type hypersensitivity can be stimulated by heparin improving the T-cell response after stimulation with this drug.
23. Pichler WJ. Delayed drug hypersensitivity reactions. Ann Intern Med 2003; 139:683-693.
24. Posadas SJ, Leyva L, Torres MJ, et al. Subjects with allergic reactions to drugs show polarized patterns of cytokine expression depending on the chronology of the clinical reaction. J Allergy Clin Immunol 2000; 106:769-776.
25. Posadas SJ, Padial A, Torres MJ, et al. Delayed reactions to drugs show a Th1 profile and levels of perforin, granzyme B and Fas-L related to disease severity. J Allergy Clin Immunol 2002; 109:155-161.
26. Brugnolo F, Annunziato F, Sampognaro S, et al. Highly Th2-skewed cytokine profile of betalactam-specific T cells from non atopic subjects with adversedrug reactions. J Immunol 1999; 163:1053-1059.
27. Hari Y, Frutig-Schnyder K, Hurni M, et al. T cell involvement in cutaneous drug eruptions. Clin Exp Allergy 2001; 31:1398-1408.
28. Naisbitt DJ, Pirmohamed M, Park BK. Immunopharmacology of hypersensitivity reactions to drugs. Curr Allergy Asthma Rep 2003; 3:22-29.
29. Fernandez TD, Mayorga C, Torres MJ, et al. Cytokine and chemokine expression in the skin from patients with maculopapular exanthema to drugs. Allergy 2008; 63:712-719. In the skin of patients with exanthematic reactions to drugs can be shown a cellular infiltrate with CD4 cells that expressed Th1 cytokines and chemokines.
30. Homey B, Alenius H, Muller A, et al. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med 2002; 8:157-165.
31. Flier J, Boorsma DM, van Beek PJ, et al. Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation. J Pathol 2001; 194:398-405.
32. Vestergaard C, Bang K, Gesser B, et al. A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin. J Invest Dermatol 2000; 115:640-646.
33. Soler D, Humphreys TL, Spinola SM, Campbell JJ. CCR4 versus CCR10 in human cutaneous TH lymphocyte trafficking. Blood 2003; 101:1677-1683.
34. Reiss Y, Proudfoot AE, Power CA, et al. CC chemokine receptor CCR4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin. J Exp Med 2001; 194:1541-1547.
35. Campbell JJ, Haraldsen G, Pan J, et al. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 1999; 400:776-780.
36. Shimada Y, Takehara K, Sato S. Both Th1 and Th2 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis. J Dermatol Sci 2004; 34:201-208.
37. Tapia B, Morel E, Martn-Daz MA, et al. Up-regulation of CCL17, CCL22 and CCR4 in drug-induced maculopapular exanthema. Clin Exp Allergy 2007; 37:704-713.
38. Rengarajan J, Szabo SJ, Glimcher LH. Transcriptional regulation of Th1/Th2 polarization. Immunol Today 2000; 21:479-483.
39. Mullen AC, High FA, Hutchins AS, et al. Role of T-bet in commitment of Th1 cells before IL-12-dependent selection. Science 2001; 292:1907-1910.
40. Cornejo-Garcia JA, Fernandez TD, Torres MJ, et al. Differential cytokine and transcription factor expression in patients with allergic reactions to drugs. Allergy 2007; 62:1429-1438. Monitoring of the acute response in allergic reactions to drugs shows only a cytokine pattern compatible with immediate (Th2) or nonimmediate (Th1) reaction. Transcription factors such as GATA-3 and C-maf are involved in Th2 reaction and T-bet in Th1 reactions.
41. Adkinson NF. Drug allergy. In: Adkinson NF, Yunginger JW, Busse WW, Bochner BS, Holgate ST, Simons FE, editors. Middleton's allergy: principles and practice, vol. 2. Philadelphia: Mosby Inc; 2003. pp. 1679-1694.
42. Matés JM, Pérez-Gómez C, Blanca M. Chemical and biological activity of free radical scavengers in allergic diseases. Clin Chem Acta 2000; 296:1-15.
43. Briganti S, Picardo M. Antioxidant activity, lipid peroxidation and skin diseases. What's new? J Eur Acad Dermatol Venereol 2003; 17:663-669.
44. Nadeem A, Chhabre SK, Masood A, Raj HG. Increased oxidative stress and altered levels of antioxidants in asthma. J Allergy Clin Immunol 2003; 111:72-78.
45. Cornejo-Garcia JA, Mayorga C, Torres MJ, et al. Antioxidant enzyme activities and expression and oxidative damage in patients with nonimmediate reactions to drugs. Clin Exp Immunol 2006; 145:287-295.
46. Torres MJ, Corzo JL, Leyva L, et al. Differences in the immunological responses in drug- and virus-induced cutaneous reactions in children. Blood Cells Molecules Dis 2003; 30:124-131.
47. Shiohara T, Kano Y. A complex interaction between drug allergy and viral infection. Clin Rev Allergy Immunol 2007; 33:124-133. This review emphasizes the mechanisms that are involved in drug reactions and the relapse of viral infections.
48. Aihara Y, Ito S-I, Kobayashi Y, et al. Carbamazepine-induced hypersensitivity syndrome associated with transient hypogammaglobulinaemia and reactivation of human herpesvirus 6 infection demonstrated by real-time quantitative polymerase chain reaction. Br J Dermatol 2003; 149:165-169.
49. González-Delgado P, Blanes M, Soriano V, et al. Erythema multiforme to amoxicillin with concurrent infection by Epstein-Barr virus. Allergol Immunopathol 2006; 34:76-78.
50. Renn CN, Straff W, Dorfmuller A, et al. Amoxicillin-induced exanthema in young adults with infectious mononucleosis: demonstration of drug-specific lymphocyte reactivity. Br J Dermatol 2002; 147:1166-1170.
51. Kano Y, Inaoka M, Shiohara T. Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogamma-globulinemia. Arch Dermatol 2004; 140:183-188.
52. Luque I, Leyva L, José Torres M, et al. In vitro T-cell responses to beta-lactam drugs in immediate and nonimmediate allergic reactions. Allergy 2001; 56:611-618.
53. Padial A, Antunez C, Blanca-Lopez N, et al. Nonimmediate reactions to beta-lactams: diagnostic value of skin testing and drug provocation test. Clin Exp Allergy 2008; 38:822-828. The role of skin testing in exanthematic reactions using patients allergic to betalactams shows that sensitivity is lower than previously reported and that further studies are required for confirmation of these findings.